The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology (한방안이비인후피부과학회지)

The Society of Korean Medicine Ophthalmology, Otolaryngology & Dermatology (대한한방안이비인후피부과학회)
권호 표지
DOI QR코드

DOI QR Code

A Case of Recurrent Herpes Zoster after Coronavirus Disease-2019 (COVID-19) Vaccination

코로나바이러스감염증-19 (COVID-19) 백신 접종 후 재발한 대상포진 치험 1례

  • Song, Ji-Hun (Department of Ophthalmology, Otolaryngology & Dermatology, College of Korean medicine, Dongshin University) ;
  • Park, Soo-Yeon (Department of Ophthalmology, Otolaryngology & Dermatology, College of Korean medicine, Dongshin University)
  • 송지훈 (동신대학교 한의과대학 한방안이비인후피부과학교실) ;
  • 박수연 (동신대학교 한의과대학 한방안이비인후피부과학교실)
  • Received : 2021.10.04
  • Accepted : 2021.11.10
  • Published : 2021.11.25
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : This study reports a 42-year old female inpatient who visited for recurrent herpes zoster on the right hand and right side of the face on 5 days after coronavirus disease 2019 (COVID-19) vaccination. She already had 2 times of herpes zoster prior to this outbreak. Methods : During 10 days of hospitalization, both treatments were simultaneously applied to her. For Korean medical treatment, acupuncture, herbal medicine including Sipjeondaebo-tang, and Hominis Placenta pharmacopuncture were mainly used. Collaborating with internal medicine of our hospital, essential medications for herpes zoster including antihistamine, corticosteroid, and acyclovir were administered. To assess symptoms, taking photos and numerical rating scale(NRS) were used. Results : On the 3rd day of hospitalization, erythema on the right hand disappeared. On the 4th day, discomfort arisen by zoster lesions dropped from NRS 8, which was initially evaluated, to NRS 0. Facial lesion also steadily improved. At the moment of discharge, erythema on the right side of oral angle disappeared and mild traces of vesicular lesions remained on the right hand. Conclusions : Considering her medical history, the recent recurrent herpes zoster was suspected as an adverse event of COVID-19 vaccination. Unlike general course of herpes zoster, the skin lesions and discomfort were rapidly improved owing to the collaborated treatment during the 10 days. This study may be the first literature on herpes zoster following COVID-19 vaccination in Korea.

Keywords

Acknowledgement

이 논문은 동신대학교 학술연구비에 의하여 연구되었음.

References

  1. The Text Complication Committee of Korean Dermatological Association. Text of Traditional Korean Dermatology & Surgery. Busan:Seonu. 2007:427-31.
  2. The Department of Dermatology of Seoul National University College of Medicine. Dermatology for Medical Students. 4th ed. Seoul:Korea Medical Book. 2017:148-50.
  3. Joesoef RM, Harpaz R, Leung J, Bialek SR. Chronic medical conditions as risk factors for herpes zoster. Mayo Clin Proc. 2012;87(10):961-7. https://doi.org/10.1016/j.mayocp.2012.05.021
  4. Chen MH, Wei HT, Su TP, Li CT, Lin WC, Chang WH, et al. Risk of depressive disorder among patients with herpes zoster: a nationwide population-based prospective study. Psychosom Med. 2014;76(4):285-91. https://doi.org/10.1097/PSY.0000000000000051
  5. Lin SY, Liu JH, Yeh HC, Lin CL, Tsai IJ, Chen PC, et al. Association between herpes zoster and end stage renal disease entrance in chronic kidney disease patients: a population-based cohort study. Eur J Clin Microbiol Infect Dis. 2014;33(10):1809-15. https://doi.org/10.1007/s10096-014-2143-6
  6. Heymann AD, Chodick G, Karpati T, Kamer L, Kremer E, Green MS, et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection. 2008;36(3):226-30. https://doi.org/10.1007/s15010-007-6347-x
  7. Guignard AP, Greenberg M, Lu C, Rosillon D, Vannappagari V. Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997-2006. Infection. 2014;42(4):729-35. https://doi.org/10.1007/s15010-014-0645-x
  8. Suaya JA, Chen SY, Li Q, Burstin SJ, Levin MJ. Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States. Open Forum Infect Dis. 2014;1(2):ofu049. https://doi.org/10.1093/ofid/ofu049
  9. Antoniou T, Zheng H, Singh S, Juurlink DN, Mamdani MM, Gomes T. Statins and the risk of herpes zoster: a population-based cohort study. Clin Infect Dis. 2014;58(3):350-6. https://doi.org/10.1093/cid/cit745
  10. Chung SD, Tsai MC, Liu SP, Lin HC, Kang JH. Herpes zoster is associated with prior statin use: a population-based case-control study. PLoS One. 2014;9(10):e111268. https://doi.org/10.1371/journal.pone.0111268
  11. Kim HJ, Kang HR, Seo HS. Analysis of the Effect on Korean Medicine Alone and Korean-Western Medicine Combination Treatment for Herpes Zoster through Domestic Case Report. J Korean Med Ophthalmol Otolaryngol Dermatol. 2021;34(1):44-55. https://doi.org/10.6114/JKOOD.2021.34.1.044
  12. Kim ST, Choi AR, Koo DM. A Case Report of Herpes Zoster in Tae-eumin Improved with Yeoldahanso-tang. J Sasang Constitut Med. 2012;24(2):71-7. https://doi.org/10.7730/JSCM.2012.24.2.071
  13. European Medicines Agency (EMA). Committee for Medicinal Products for Human Use (CHMP). Assessment Report - Comirnaty (Pfizer/BioNTech). 19 February 2021 EMA/707383/2020[Internet]. Amsterdam (Netherlands): EMA; 2021[cited 2021 May 7]. Available from: https://www.ema.europa.eu/en/documents/assessment-report/comirnaty-epar-public-assessment-report_en.pdf.
  14. European Medicines Agency (EMA). Committee for Medicinal Products for Human Use (CHMP). Assessment Report - COVID-19 Vaccine AstraZeneca. 29 January 2021 EMA/94907/2021[Internet]. Amsterdam (Netherlands): EMA; 2021[cited 2021 May 7]. Available from: https://www.ema.europa.eu/en/documents/assessment-report/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-public-assessment-report_en.pdf.
  15. European Medicines Agency (EMA). Committee for Medicinal Products for Human Use (CHMP). Assessment Report - COVID-19 Vaccine Moderna. 11 March 2021 EMA/15689/2021[Internet]. Amsterdam (Netherlands): EMA; 2021[cited 2021 May 7]. Available from: https://www.ema.europa.eu/en/documents/assessment-report/covid-19-vaccine-moderna-epar-public-assessment-report_en.pdf.
  16. Korea Disease Control and Prevention Agency. 2021.9.23. Weekly Adverse Events after COVID-19 Vaccination[Internet]. Cheongju (Republic of Korea): Korea Disease Control and Prevention Agency; 2021 Sep 23[cited 2021 Sep 26]. Available from: https://ncv.kdca.go.kr/board.es?mid= a11707010000&bid=0032#content.
  17. Kim YH. Cheongganguigam. 5th ed. Seoul:Seongbosa. 2001:364-8.
  18. Cho YS, Sim SY. A Review on the Pharmacopuncture Used in Herpes Zoster Related Articles Published in the Journal of Korean Medicine. J Korean Med Ophthalmol Otolaryngol Dermatol. 2016;29(1):113-22. https://doi.org/10.6114/JKOOD.2016.29.1.113
  19. Jung KH, Kim MS, Hwang HS, Jeon JC, Park JE, Lee TH, et al. Case Report of Three Cases of Idiopathic Oculomotor Nerve Palsy Treated with Hominis Placenta Pharmacopuncture. Journal of Pharmacopuncture. 2009;12(1):91-7. https://doi.org/10.3831/KPI.2009.12.1.091
  20. Rhee DH, Choi JH, Park SY, Kim JH. Clinical Study of Three Cases of Recurrent Peripheral Facial Nerve Palsy with Sequelae. J Korean Med Ophthalmol Otolaryngol Dermatol. 2012;25(4):57-69. https://doi.org/10.6114/JKOOD.2012.25.4.057
  21. Lee SC. Clinician's Dermatology. Seoul:Korean medbook Inc. 2016:151-3.
  22. Yawn BP, Wollan PC, Kurland MJ, St Sauver JL, Saddier P. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc. 2011;86(2):88-93. https://doi.org/10.4065/mcp.2010.0618
  23. Raza N, Iqbal P, Anwer J. Recurrence of herpes zoster in an immunocompetent adult male. J Ayub Med Coll Abbottabad. 2005;17(3):80-1.
  24. Qian J, Macartney K, Heywood AE, Sheridan S, Liu B. Risk of recurrent herpes zoster in a population-based cohort study of older adults. J Am Acad Dermatol. 2021;85(3):611-8. https://doi.org/10.1016/j.jaad.2020.06.1013
  25. Shiraki K, Toyama N, Daikoku T, Yajima M. Herpes Zoster and Recurrent Herpes Zoster. Open Forum Infect Dis. 2017;4(1):ofx007. https://doi.org/10.1093/ofid/ofx007
  26. Kim YJ, Lee CN, Lee MS, Lee JH, Lee JY, Han K, et al. Recurrence Rate of Herpes Zoster and Its Risk Factors: a Population-based Cohort Study. J Korean Med Sci. 2019;34(2):e1. https://doi.org/10.3346/jkms.2019.34.e1
  27. Jeong SK, Kim IH. Recurrence Rate of Herpes Zoster during the Previous Decade. Korean J Dermatol. 2012;50(4):287-9.
  28. Song JY, Cheong HJ, Kim SR, Lee SE, Kim SH, Noh JY, et al. Early safety monitoring of COVID-19 vaccines in healthcare workers. J Korean Med Sci. 2021;36(15):e110. https://doi.org/10.3346/jkms.2021.36.e110
  29. Kim SH, Wi YM, Yun SY, Ryu JS, Shin JM, Lee EH, et al. Adverse events in healthcare workers after the first dose of ChAdOx1 nCoV-19 or BNT-162b2 mRNA COVID-19 vaccination: a single center experience. J Korean Med Sci. 2021;36(14):e107. https://doi.org/10.3346/jkms.2021.36.e107
  30. Aksu SB, Ozturk GZ. A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect?. Clin Exp Vaccine Res. 2021;10(2):198-201. https://doi.org/10.7774/cevr.2021.10.2.198
  31. Bostan E, Yalici-Armagan B. Herpes zoster following inactivated COVID-19 vaccine: A coexistence or coincidence?. J Cosmet Dermatol. 2021;20(6):1566-7. https://doi.org/10.1111/jocd.14035
  32. Arora P, Sardana K, Mathachan SR, Malhotra P. Herpes zoster after inactivated COVID-19 vaccine: A cutaneous adverse effect of the vaccine. J Cosmet Dermatol. 2021;10.1111/jocd.14268.
  33. Lee C, Cotter D, Basa J, Greenberg HL. 20 Post-COVID-19 vaccine-related shingles cases seen at the Las Vegas Dermatology clinic and sent to us via social media. J Cosmet Dermatol. 2021;20(7):1960-4. https://doi.org/10.1111/jocd.14210
  34. Chiu HH, Wei KC, Chen A, Wang WH. Herpes zoster following COVID-19 vaccine: report of 3 cases. QJM. 2021:hcab208.
  35. Thimmanagari K, Veeraballi S, Roach D, Al Omour B, Slim J. Ipsilateral Zoster Ophthalmicus Post COVID-19 Vaccine in Healthy Young Adults. Cureus. 2021;13(7):e16725.
  36. David E, Landriscina A. Herpes Zoster Following COVID-19 Vaccination. J Drugs Dermatol. 2021;20(8):898-900. https://doi.org/10.36849/JDD.6146
  37. Eid E, Abdullah L, Kurban M, Abbas O. Herpes zoster emergence following mRNA COVID-19 vaccine. J Med Virol. 2021;93(9):5231-2. https://doi.org/10.1002/jmv.27036
  38. Tessas I, Kluger N. Ipsilateral herpes zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine. J Eur Acad Dermatol Venereol. 2021;35(10):e620-2.
  39. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of Immune Response in Patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762-8. https://doi.org/10.1093/cid/ciaa248
  40. Wang B, Guo S, Yao Y, Li Y, Zhang G. Dermatologists may need to pay more 8attention to herpes zoster during the pandemic of COVID-19. Infect Dis (Lond). 2020;52(12):917-8. https://doi.org/10.1080/23744235.2020.1797158
  41. Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586(7830):589-93. https://doi.org/10.1038/s41586-020-2639-4
  42. Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396(10249):467-78. https://doi.org/10.1016/S0140-6736(20)31604-4
  43. van Dam CS, Lede I, Schaar J, Al-Dulaimy M, Rosken R, Smits M. Herpes Zoster after COVID vaccination. Int J Infect Dis. 2021;111:169-71. https://doi.org/10.1016/j.ijid.2021.08.048
  44. Brambilla L, Maronese CA, Tourlaki A, Veraldi S. Herpes zoster following COVID-19: a report of three cases. Eur J Dermatol. 2020;30(6):754-6. https://doi.org/10.1684/ejd.2020.3924
  45. Wei L, Zhao J, Wu W, Zhang Y, Fu X, Chen L, et al. Decreased absolute numbers of CD3+ T cells and CD8+ T cells during aging in herpes zoster patients. Sci Rep. 2017;7(1):1-8. https://doi.org/10.1038/s41598-016-0028-x
  46. Wang Y, Zhu G, Lai W, Zheng Y. Transmission of varicella-zoster-virus (VZV) in family: calls for attention during COVID-19 outbreak. J Cosmet Dermatol. 2020;19(12):3166-7. https://doi.org/10.1111/jocd.13808